![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Dr. Rafik H. Bishara, World Courier and Sensitech Present Clinical Trial Webinar Online Seminar Focuses on ‘Global Cold-Chain Regulations Influencing Logistics of Clinical Trial Materials’ Beverly, Mass., April 4, 2007 – Sensitech Inc., a global leader in cold chain visibility solutions, will sponsor an upcoming online seminar focused on protecting clinical trial materials (CTMs) and investigational medicinal products (IMPs) as they progress through the global cold chain. Sensitech is a wholly owned subsidiary of Carrier Corp., which is a business unit of United Technologies Corp. (NYSE:UTX). The “Global Cold-Chain Regulations Influencing Logistics of Clinical Trial Materials” Webinar will be held on Tuesday, April 24 at 2 p.m. Eastern time. Dr. Rafik H. Bishara, chair of the Pharmaceutical Cold Chain Discussion Group (PCCDG), and Michael Connolly, director of U.S. Operations for World Courier Inc., will outline some of the risks that must be considered when selecting a packaging system, choosing transportation partners and developing a contingency plan. Temperature excursions of cold-chain CTMs and IMPs can significantly alter their efficacy and potency. With many clinical specimens required to be frozen at -78.5 degrees Celsius or maintained at refrigerated temperatures between 2 and 8 degrees Celsius, even temperature variations of just a few degrees can affect the integrity of the specimens. Compromised or adulterated CTMs or IMPs can delay the introduction of new medicines to patients. If temperature excursions were to go unnoticed, it could harm patients involved with the clinical trial or negatively affect the outcome of the trial due to a lack of consistency of drug efficacy. As clinical studies move beyond primary cities and into more remote investigator site locations, there are new challenges to maintaining the cold chain. Components of a clinical trial often occur in different countries, which have their own regulations regarding the clinical trial process. Additionally, because of the various exchange and drop-off points, distribution environments often involve lengthy clearance procedures at customs, several modes of transportation, numerous carriers and couriers, specialty packaging solutions, different climate zones and seasonal changes. Thus, temperature control during the handling, storage and distribution of these cold-chain products is not only challenging but also critical. PCCDG Chair Dr. Rafik H. Bishara will give a review of global regulatory and
standards-based guidance for Good Cold Chain Management Practices covering
CTMs and IMPs, including Good Clinical Practice (GCP), Good Distribution Practice
(GDP), Good Storage Practice (GSP), United States Pharmacopeia <1079>, World Courier Director of U.S. Operations Michael Connolly will highlight the practical application of these regulatory requirements and guidance standards with case studies that detail how industry leaders are reducing risk and ensuring the integrity of their shipments within the temperature-controlled logistics chain. Sensitech’s Director of Strategic Marketing for Life Sciences Henry Ames will give a brief description of Sensitech’s validated temperature data loggers and professional service offerings. These solutions are geared toward meeting regulatory demands and mitigating risk. A question-and-answer session will follow the presentations.
About Dr. Rafik H. Bishara, chair of the Pharmaceutical Cold Chain Discussion Group (PCCDG) About Michael Connolly, director of U.S. Operations, World Courier Inc. About World Courier Inc. About Sensitech Inc.
|
![]() |
||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2008 Sensitech. All Rights Reserved. Sensitech is a business unit of Carrier Corp. |